Kuangli Bio-Tech Holdings Co (TPE:6431) ROCE %: -23.33% (As of Dec. 2025)


TPE:6431 Kuangli Bio-Tech Holdings Co Ltd TPE:6431
66 GF Score
Price NT$18.20
GF Value NT$11.76
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Kuangli Bio-Tech Holdings Co ROCE %?

Kuangli Bio-Tech Holdings Co TPE:6431 -0.27% 66 ROCE % is -23.33% as of Dec. 2025. GuruFocus rates TPE:6431 with a GF Score™ of 66/100 and a GF Value™ of NT$11.76 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kuangli Bio-Tech Holdings Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -23.33%.


Kuangli Bio-Tech Holdings Co  (TPE:6431) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Kuangli Bio-Tech Holdings Co ROCE % Related Terms


Kuangli Bio-Tech Holdings Co ROCE % Historical Data

* Premium members only.

The historical data trend for Kuangli Bio-Tech Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kuangli Bio-Tech Holdings Co ROCE % Chart

Kuangli Bio-Tech Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.88 -7.96 -13.66 -24.45 -24.78

Kuangli Bio-Tech Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.51 -22.01 -22.25 -17.43 -23.33
TPE:6431
66GF Score
Kuangli Bio-Tech Holdings Co Ltd TPE:6431
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kuangli Bio-Tech Holdings Co ROCE % Calculation

Kuangli Bio-Tech Holdings Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-179.336/( ( (910.202 - 307.954) + (1187.334 - 342.289) )/ 2 )
=-179.336/( (602.248+845.045)/ 2 )
=-179.336/723.6465
=-24.78 %

Kuangli Bio-Tech Holdings Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=-200.284/( ( (1149.06 - 277.405) + (1187.334 - 342.289) )/ 2 )
=-200.284/( ( 871.655 + 845.045 )/ 2 )
=-200.284/858.35
=-23.33 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -23.33% mean?
Kuangli Bio-Tech Holdings Co (TPE:6431) has a ROCE % of -23.33% as of Dec. 2025.
Is Kuangli Bio-Tech Holdings Co's ROCE % too high?
Kuangli Bio-Tech Holdings Co's current ROCE % is -23.33%. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's ROCE % compare to PG and CL?
Kuangli Bio-Tech Holdings Co's ROCE % of -23.33% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.78, based on 1,938 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current ROCE % is -23.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.76, compared to a current price of NT$18.20 — trading 54.8% above its estimated fair value. The current ROCE % is -23.33%. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current ROCE % is -23.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?

Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued. The current stock price of NT$18.20 is trading 54.8% above its estimated GF Value™ of NT$11.76. GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.

Key valuation signals for TPE:6431:

  • ROCE %: -23.33%
  • GF Value™: NT$11.76 vs. price of NT$18.20 (54.8% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kuangli Bio-Tech Holdings Co Business Description

Address North Sound Road, Suite 102, Cannon Place, George Town, Grand Cayman, CYM
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
66GF Score

Get the complete analysis for TPE:6431

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.20
Price
NT$11.76
GF Value